Phathom Pharmaceuticals annual return on equity
2019
2020
2021
Phathom Pharmaceuticals Return on Equity (ROE) Growth & History (PHAT)
Phathom Pharmaceuticals's return on equity was −108.01% for fiscal 2021.
View full Phathom Pharmaceuticals company overviewPhathom Pharmaceuticals annual return on equity history
| Fiscal year | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| 2021 | 2021-12-31 | −108.01% | −46.87 pp |
| 2020 | 2020-12-31 | −61.14% | +163.98 pp |
| 2019 | 2019-12-31 | −225.11% | — |
Phathom Pharmaceuticals quarterly return on equity
Q4.19
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
| Fiscal quarter | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| Q2 2022 | 2022-06-30 | −328.15% | −303.49 pp |
| Q1 2022 | 2022-03-31 | −73.81% | −54.38 pp |
| Q4 2021 | 2021-12-31 | −40.80% | −10.16 pp |
| Q3 2021 | 2021-09-30 | −31.12% | −11.34 pp |
| Q2 2021 | 2021-06-30 | −24.66% | −14.03 pp |
| Q1 2021 | 2021-03-31 | −19.43% | −10.21 pp |
| Q4 2020 | 2020-12-31 | −30.64% | +229.00 pp |
| Q3 2020 | 2020-09-30 | −19.78% | — |
| Q2 2020 | 2020-06-30 | −10.63% | — |
| Q1 2020 | 2020-03-31 | −9.23% | — |
| Q4 2019 | 2019-12-31 | −259.64% | — |
Phathom Pharmaceuticals return on equity trends
Between the periods ended 2019-12-31 and 2021-12-31, Phathom Pharmaceuticals's return on equity increased from −225.11% to −108.01%, a change of +117.10 percentage points. The latest reported quarter, Q2 2022, shows −328.15%.
About the metric
What return on equity (ROE) means
Return on equity (ROE) measures how much net income a company generates relative to shareholders’ equity. It can help evaluate how efficiently equity capital is used, but unusually high or negative values may reflect leverage, losses, or a small equity base.
Calculation and source
How return on equity is calculated
TickerStat calculates ROE as SEC-reported net income divided by average stockholders’ equity at the beginning and end of the fiscal period. Periods with missing or non-positive average equity are omitted. Quarterly ROE uses quarterly net income and is not annualized. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Phathom Pharmaceuticals source filings ↗